Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshiyuki Kitano

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
European Journal of Haematology|September 9, 2025
Significance of Pre- and Posttransplant Minimal Residual Disease on Transplant Outcomes in Core-Binding Factor Acute Myeloid LeukemiaChika Tokuda, Makoto Iwasaki, Junya Kanda, et al.
Leukemia|April 21, 2025
Impact of myelodysplasia-related gene mutations and residual mutations at remission in venetoclax/azacitidine for AMLYoshikazu Ikoma, Nobuhiko Nakamura, Yuto Kaneda, et al.
Scientific Reports|February 7, 2026
Impact of venetoclax trough levels on safety and efficacy in the treatment of acute myeloid leukemiaHiromi Hayashi, Takeo Yamagiwa, Junya Kanda, et al.
Blood Cancer Discovery|July 15, 2022
Amplified EPOR/JAK2 Genes Define a Unique Subtype of Acute Erythroid LeukemiaJune Takeda, Kenichi Yoshida, Masahiro M Nakagawa, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
European Journal of Haematology|September 9, 2025
Significance of Pre- and Posttransplant Minimal Residual Disease on Transplant Outcomes in Core-Binding Factor Acute Myeloid LeukemiaChika Tokuda, Makoto Iwasaki, Junya Kanda, et al.
Leukemia|April 21, 2025
Impact of myelodysplasia-related gene mutations and residual mutations at remission in venetoclax/azacitidine for AMLYoshikazu Ikoma, Nobuhiko Nakamura, Yuto Kaneda, et al.
Scientific Reports|February 7, 2026
Impact of venetoclax trough levels on safety and efficacy in the treatment of acute myeloid leukemiaHiromi Hayashi, Takeo Yamagiwa, Junya Kanda, et al.
Blood Cancer Discovery|July 15, 2022
Amplified EPOR/JAK2 Genes Define a Unique Subtype of Acute Erythroid LeukemiaJune Takeda, Kenichi Yoshida, Masahiro M Nakagawa, et al.
Pageof 8